Short Terms Effects of Medial Branch Block vs Para-spinal Muscle Injection in Patients With Non-specific CLBP
Unknown statusPhase 3NCT02521519
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
This study compares the efficacy of medial branch block (MBB) vs. paravertebral deep intramuscular (PDI) injection for pain relief in chronic low back pain. Based on randomization in first intervention session, one side receives MBB and the other side takes PDI and in second session the pattern reverses.
Study details
- Official title
- Short Term Effects of Medial Branch Block vs Para-spinal Injection in Muscle Patients With Non-specific Chronic Low Back Pain
- Conditions
- Interventions
- Other: Medial branch block in one side
- Other: paravertebral deep intramuscular (PDI) injection
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Start date
- 2014-08
- Primary completion
- 2020-03
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * CLBP of non-malignant origin fulfilling the following criteria: * Pain lasting for at least three months * Pain in both the left and right sides of the back * Pain below the L2 vertebral body * Lumbar spine CT scan or MRI done in the last 2 years * Average visual analogue scale (VAS) for pain ≥4/10 on each side for the 3 days * Cognitive and physical ability to provide informed consent in English or French Exclusion Criteria: * Neurologic signs or symptoms suggesting nerve root involvement * Strictly unilateral Low Back Pain (LBP) * CT scan or MRI findings suggestive of pain etiology beyond degenerative spine disease * Vascular malformations * Tumor * Infection * Fractures * DISH (Diffuse idiopathic skeletal hyperostosis) * Patients who have received injections of any type or acupuncture therapy to the low back in the last 3 months * Prior spine surgery * Local or systemic infection * Bleeding disorder or the use of anticoagulation medications but for low-dose aspirin * Known allergy to amid local anesthetics * Active insurance claim (CSST, SAAQ) * Uncontrolled psychiatric condition
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02521519